Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk. | Front Oncol | 2021 | 34926279 | PubTator, text mining | PubMed |
| Inhibitors of the Bub1 spindle assembly checkpoint kinase: synthesis of BAY-320 and comparison with 2OH-BNPP1. | R Soc Open Sci | 2021 | 34925867 | PubTator, text mining | PubMed |
| Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma. | Front Immunol | 2021 | 34925377 | PubTator, text mining | PubMed |
| Integrative multi-omics identifies high risk multiple myeloma subgroup associated with significant DNA loss and dysregulated DNA repair and cell cycle pathways. | BMC Med Genomics | 2021 | 34922559 | PubTator, text mining | PubMed |
| SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury. | Signal Transduct Target Ther | 2021 | 34921131 | PubTator, text mining | PubMed |
| NFAT as a Biomarker and Therapeutic Target in Non-Small Cell Lung Cancer-Related Brain Metastasis. | Front Oncol | 2021 | 34917508 | PubTator, text mining | PubMed |
A Next-Generation Sequencing of Plasma Exosome-Derived microRNAs and Target Gene Analysis with a Microarray Database of Thermally Injured Skins: Identification of Blood-to-Tissue Interactions at Early Burn Stage. | J Inflamm Res | 2021 | 34916825 | PubTator, text mining | PubMed |
| Transcriptomics of single dose and repeated carbon black and ozone inhalation co-exposure highlight progressive pulmonary mitochondrial dysfunction. | Part Fibre Toxicol | 2021 | 34911549 | PubTator, text mining | PubMed |
| KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma. | Nat Commun | 2021 | 34893606 | PubTator, text mining | PubMed |
| Alterations of Chromatin Regulators in the Pathogenesis of Urinary Bladder Urothelial Carcinoma. | Cancers (Basel) | 2021 | 34885146 | PubTator, text mining | PubMed |
| The Role of EREG/EGFR Pathway in Tumor Progression. | Int J Mol Sci | 2021 | 34884633 | PubTator, text mining | PubMed |
| Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression. | Int J Mol Sci | 2021 | 34884561 | PubTator, text mining | PubMed |
| The Effect of Hypoxic and Normoxic Culturing Conditions in Different Breast Cancer 3D Model Systems. | Front Bioeng Biotechnol | 2021 | 34869246 | PubTator, text mining | PubMed |
| Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation. | Front Oncol | 2021 | 34868993 | PubTator, text mining | PubMed |
| Predicting Bone Metastasis Using Gene Expression-Based Machine Learning Models. | Front Genet | 2021 | 34858485 | PubTator, text mining | PubMed |
| Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer. | J Exp Clin Cancer Res | 2021 | 34857028 | PubTator, text mining | PubMed |
| Counteraction between Astrin-PP1 and Cyclin-B-CDK1 pathways protects chromosome-microtubule attachments independent of biorientation. | Nat Commun | 2021 | 34853300 | PubTator, text mining | PubMed |
| BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway. | J Exp Clin Cancer Res | 2021 | 34852826 | PubTator, text mining | PubMed |
| SKA3 Serves as a Biomarker for Poor Prognosis in Kidney Renal Papillary Cell Carcinoma. | Int J Gen Med | 2021 | 34849004 | PubTator, text mining | PubMed |
| Lipid raft-disrupting miltefosine preferentially induces the death of colorectal cancer stem-like cells. | Clin Transl Med | 2021 | 34841679 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=45